Advanced Biomed Inc.
ADVB· Nasdaq
ADVBAdvanced Biomed Inc.
Filed Apr 15, 2025 · 10-Q · 105 days after period end · 0001213900-25-032066
| Metric | Q2 2025 | Q2 2024 |
|---|---|---|
| Net Income | -$907.90K | -$145.35K |
| EPS Diluted | -$0.05 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Advanced Biomed Inc. · CIK 1941029 · Engraved from SEC EDGAR
ended Dec 31, 2024 · filed Apr 15, 2025 · 105 d after period end
